Kamada Ltd. — Director's Dealing 2026

Mar 21, 2026

EAN

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

| 1. Name and Address of Reporting Person*
Brenner Yael | | 2. Date of Event Requiring Statement
(Month/Day/Year)
03/16/2026 | 3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ] | |
| --- | --- | --- | --- | --- |
| (Last) | (First) | | 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer Other
(give title below) (specify below)
VP Quality | 5. If Amendment, Date of Original Filed
(Month/Day/Year) |
| 1A CARCOM ST.
(Street)
NESS ZIONA L3 7420131
(City) (State) (Zip) | | | | 6. Individual or Joint/Group Filing
(Check Applicable Line)
X Form filed by One Reporting Person
X Form filed by More than One Reporting Person |
| Table I – Non-Derivative Securities Beneficially Owned | | | | |
| --- | --- | --- | --- | --- |
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) | |
| Ordinary Shares | 6,266 | D | | |
| Table II – Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date
(Month/Day/Year) | | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
| | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | | | |
| Options to purchase Ordinary Shares(1) | 02/28/2023 | 08/28/2028 | Ordinary Shares | 15,000 | $6.15(2) | D | |
| Options to purchase Ordinary Shares(1) | 02/28/2024 | 08/28/2028 | Ordinary Shares | 15,000 | $6.15(2) | D | |
| Options to purchase Ordinary Shares(1) | 02/28/2025 | 08/28/2028 | Ordinary Shares | 15,000 | $6.15(2) | D | |
| Options to purchase Ordinary Shares(1) | 02/28/2026 | 08/28/2028 | Ordinary Shares | 15,000 | $6.15(2) | D | |
| Options to purchase Ordinary Shares(1) | 10/22/2026 | 10/22/2035 | Ordinary Shares | 15,000 | $7.55(2) | D | |
| Options to purchase Ordinary Shares(1) | 10/22/2027 | 10/22/2035 | Ordinary Shares | 15,000 | $7.55(2) | D | |
| Options to purchase Ordinary Shares(1) | 10/22/2028 | 10/22/2035 | Ordinary Shares | 15,000 | $7.55(2) | D | |
| Options to purchase Ordinary Shares(1) | 10/22/2029 | 10/22/2035 | Ordinary Shares | 15,000 | $7.55(2) | D | |

Explanation of Responses:

1. These options to purchase ordinary shares are exercisable using a net-exercise method
2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

/S/ Yael Brenner

03/16/2026

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.